Additional financing propels Gelmetix into clinical trial phase for treating chronic lower back pain, with first-in-human study due to take place in France and Australia
About peameThis author has not yet filled in any details.
So far peame has created 7 blog entries.
Gelmetix won 3rd place in the final of the biotech category of the prestigious EIT Health Catapult competition
Gelmetix and Stemmatters, a Portuguese company, sign collaboration agreement for development of innovative cartilage repair device for Knee Ostearthritis